NCT00759408View on ClinicalTrials.gov

The Role of Endothelin in Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

October 31, 2010

Study Completion Date

June 30, 2011

Conditions
Pulmonary Hypertension
Interventions
DRUG

BQ-123

6-120 µg/min

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT00759408 - The Role of Endothelin in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter